Michael Chlopak retired from Citigroup in 2016, after 37 years, serving as a Managing Director in the Institutional Client Group (ICG). He served >100 clients as a global leader in building Citigroup’s commercial real estate (CRE) enterprises of > $60 billion global credit lines into a top 5 League Table market share in the related capital markets enterprises, supported by strong investment grade credit metrics and ROIs.
Mr. Chlopak’s responsibilities included managing a team of 12 real estate professionals and overseeing credit, risk/portfolio management, and compliance for the North American portfolios. He also led firm wide assignments in leadership, talent development and training based on his track record and experiences in these functions. Other responsibilities included significant interface and coordination roles associated with global real estate partners in the major market hubs for Mexico/Latin America, Europe, and the Asia-Pacific region.
Mr. Chlopak is currently consulting and advising various organizations. In the academic sector, he was nominated as a Distinguished Executive-in-Residence for Rutgers Business School where he serves the Dean and senior leaders on various strategic initiatives. Also, Mr. Chlopak serves as an Advisory Board Member and senior advisor at 4 universities and is an Adjunct Faculty member at NYU’s Schack Real Estate Institute Graduate School.
George Kofinakos is Managing Director of StormHarbour in Greece. George has been CEO and Executive Director of a Private Equity Fund in Luxemburg and an Executive Board member in a number of Greek Corporates.
Mr. Kofinakos is seasoned financier, with over 25 years of experience in fund management, financial advisory, investment banking, debt and liability management, FX sales and trading in Greece and overseas.
Mr. Kofinakos holds a Bachelor in Economics and Statistics from the University of Piraeus and an MBA from Rutgers University in the US.
Gary Rodkin retired from ConAgra Foods in 2015 after 10 years as CEO. Prior to joining ConAgra, Rodkin was CEO of PepsiCo Beverages and Food North America, CEO of Tropicana, and held a variety of management roles with General Mills. He graduated Phi Beta Kappa with a BA in economics from Rutgers College in 1974 and was inducted into its Hall of Distinguished Alumni. He received an MBA from Harvard Business School in 1979. He currently serves on the boards of Simon Property Group, McCormick & Company, FeedingAmerica, and is vice chair of Rutgers Board of Overseers.
Mr. Rodkin is a Distinguished Executive-In-Residence at Rutgers and a Fellow of Executive Education at Harvard Business School.
Thomas M. Gorrie
Thomas M. Gorrie is presently a senior global business advisor to numerous organizations and has extensive worldwide healthcare experience.
He retired in 2008 from Johnson & Johnson after 35 years. At J&J, he held senior positions in research and development, marketing and sales, business development, strategic planning, international, venture capital, health policy, and general management, including the position of Company Group Chairman responsible for a large global medical device business. He most recently was a Corporate Officer and Vice President of Government Affairs and Policy worldwide.
Dr. Gorrie received his Bachelor of Arts degree from Rutgers University and his masters and doctoral degrees in chemistry from Princeton University. He completed post-doctoral studies at the Swiss Federal Institute of Technology in Zurich.
He is a Senior Fellow of the U.S. Chamber of Commerce and serves on the Boards of Duke University, Duke University Health System, the Robert Wood Johnson Foundation, and the Hun School of Princeton. He is an adjunct professor at the Rutgers Business School and a Senior Advisor of the China Association of Enterprises with Foreign Investments (CAEFI) which serves as a bridge between the Chinese government and foreign invested companies.
Julia Coronado is President and Founder of MacroPolicy Perspectives LLC, an economic research consulting form based in New York that analyzes the US economy from a global perspective with a focus on financial market linkages and demographic realities.
She currently serves on the Board of Directors of MTGE Corporation and the Pension Research Council at the Wharton School. She is a member of the Treasury Markets Practices Group and the Economic Advisory Panel of the Federal Reserve Bank of New York and a member of the Economic Studies Council at The Brookings Institution.
Ms. Coronado is an Executive in Residence and blogger for Rutgers Business School and a regular commentator on Marketplace. Ms. Coronado has more than a decade of experience as a financial market economist including serving as Chief Economist for Graham Capital Management and BNP Paribas, and as a Senior Economist at Barclays Capital.
Dick Romano has been appointed as a distinguished executive in residence.
Gerald Harvey is a Distinguished Executive-In-Residence for the Institute of Ethical Leadership at the Rutgers Business School. Mr. Harvey has forty years experience as an attorney and corporate executive. As the Executive Vice President, General Counsel and Secretary of Breeze-Eastern Corporation, a publicly-traded company, Mr. Harvey oversaw SEC, NYSE, environmental and legal compliance. He also served as a managing director of the company's subsidiaries in England and Germany and worked extensively with its Brazilian subsidiary. Prior to that Mr. Harvey was a partner in a multi-office law firm where he focused on cross-border transactions and international arbitration. For a number of years, he worked for a Japanese trading company with assignments in New York and Tokyo working extensively on international joint ventures. He began his overseas work as a foreign lawyer associate in the Tokyo office of a Japanese law firm.
As an outside attorney and as a general counsel of a corporation, Mr. Harvey worked extensively with senior managements and boards of directors on ethics and compliance matters. He also served as a member and chairman of the governing boards of a private school and a public university, served on and chaired audit committees at these institutions and served a proactive role in their respective compliance and ethics initiatives.
Mr. Harvey is a graduate of Columbia Law School, where he served as editor-in-chief of The Columbia Journal of Transnational Law, and of Rutgers University. He received an honorary Doctorate in Humane Letters from Rutgers upon completing his term as Chairman of the University's Board of Governors. At Rutgers, he and his wife have endowed the Keiko and Gerald Harvey Scholarship in Support of Women in Engineering.
Noting that the most stable, equitable and successful societies and institutions have strong traditions in values-based and ethical behaviors, Mr. Harvey seeks to use his experiences in cross-cultural environments to help advance the goals of the Institute of Ethical Leadership at the Rutgers Business School.
Michael Crocker was a senior healthcare executive at Bayer Pharmaceuticals with 35 years of broad, diversified leadership positions across finance, sales, marketing, business management, operations, project management, and managed markets. Mr. Crocker has a track record of successful oversight of mission-critical initiatives for a global healthcare leader. He led several legacy projects resulting in significant financial savings, long-term organizational efficiency improvements, revenue growth, and increased market positions. Mr. Crocker is adept at transformative team development, as well as strategic project leadership.
During his tenure as both Director of Marketing and National Field Sales Director for Bayer’s global leading Diagnostic Imaging business, Mr. Crocker led team efforts in reaching record sales revenue results each year while consistently surpassing organization’s goals. During this time the Diagnostic Imaging business achieved #1 ranking for best in industry customer relations.
Mr. Crocker established and led the MBA University relations program for the Bayer Pharmaceutical Division creating partnerships with several leading Business Schools. He is a member of the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues Board of Advisors, and was recently named a Distinguished Executive-In- Residence for the Business school upon his retirement from Bayer.
Before joining RBS, Hal had a diverse career in auditing, accounting and investing. He served two full terms as a member of the Financial Accounting Standards Board (FASB) from February 2011 to June 2021. Prior to joining the FASB, Hal was a Greenwich, CT-based partner at Carlson Capital, L.P., an alternative investments firm with operations in the U.S. and Europe. He joined its relative value arbitrage team in 2000 and was a member of the firm’s management and investment committees. As a senior portfolio manager, he focused on the financial services industry, including both public and private companies. From 1995 to 2000, Hal was a senior equity analyst initially with KBW, Inc. (formerly Keefe, Bruyette & Woods Inc.), and then with Schroder & Company, Inc. (subsequently acquired by Citigroup Inc.), both based in New York City. From 1993 to 1995, he was Chief Financial Officer for New York-based Nafinsa Securities, Inc., and various other subsidiaries, of Nacional Financiera, SNC, the primary development bank for the Mexican government. Prior to that, he spent 13 years with Ernst & Young, including the firm’s National office as well as client-serving roles in New Orleans and New York, where he was a partner in the financial services division.
Hal is serving on our Road to CPA Committee and helping to update our accounting curriculum for the latest CPA exam changes. In addition, Hal is assisting a Ph.D. Accounting student with her dissertation. During the fall 2021 semester, Hal did an excellent presentation at our RBS 29th Annual Conference on PBFEAM.
Erin Byrne has been appointed as a distinguished executive in residence.
Dan Grimm has been appointed as a distinguished executive in residence.
In 2019, Jimmy Hanson was re-appointed as a distinguished executive in residence by Dean Lei.